Article
Chemistry, Medicinal
Haosu Huang, Meng Wang, Zimeng Guo, Di Wu, Hanyue Wang, Yan Jia, Honghui Liu, Junjie Ding, Jie Peng
Summary: This study demonstrated that rutaecarpine (RUT) alleviated acute pancreatitis (AP) through upregulating calcitonin gene-related peptide (CGRP) and suppressing the MAPK and NF-κB signaling pathways. The findings suggest that RUT may serve as a potential therapeutic option for AP patients.
PHYTOTHERAPY RESEARCH
(2021)
Review
Oncology
Wan-Jun Ma, You-Cong Yin, Bi-Kui Zhang, Yuan-Jian Li, Wen-Qun Li
Summary: CGRP serves as a key neurotransmitter in sensory nerves and plays a crucial role in cardiovascular smooth muscle relaxation, protection against cardiac issues, and regulation of gastrointestinal function. Drugs like nitroglycerine and rutaecarpine have been shown to increase the synthesis and release of CGRP, leading to therapeutic effects in cardiovascular and gastrointestinal diseases.
MOLECULAR MEDICINE REPORTS
(2021)
Article
Biochemistry & Molecular Biology
Stephanie Simoncini, Simon Toupance, Carlos Labat, Sylvie Gautier, Chloe Dumoulin, Laurent Arnaud, Maria G. Stathopoulou, Sophie Visvikis-Siest, Pascal M. Rossi, Athanase Benetos, Francoise Dignat-George, Florence Sabatier
Summary: This study investigates the relationship between atherosclerotic cardiovascular disease (ASCVD), inflammation markers, and circulating endothelial progenitor cells. The findings suggest that ASCVD impairs the colony forming capacity and angiogenic properties of endothelial colony forming cells (ECFC) in a severity-dependent manner. Additionally, alteration of ECFC is associated with increased senescent phenotype and IL-6 levels.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Endocrinology & Metabolism
Ximiao Ma, Xiaowu Wang
Summary: In this study, it was found that TMP can protect EPCs from senescence by activating the NRF2 pathway. TMP treatment improved the pathological condition and cardiovascular indicators of PAH rats.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
(2023)
Review
Biochemistry & Molecular Biology
Adriano Bonura, Nicoletta Brunelli, Marilena Marcosano, Gianmarco Iaccarino, Luisa Fofi, Fabrizio Vernieri, Claudia Altamura
Summary: The calcitonin gene-related peptide (CGRP) is a neuropeptide with complex systemic impact beyond nociception. It plays a crucial role in vasodilation, inflammation, intestinal motility, and apoptosis. CGRP has contradictory effects, acting as a potent vasodilator in the cardiovascular system but not inducing arterial hypertension. It also exhibits both anti-inflammatory and pro-inflammatory effects as an immunomodulator.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Cell & Tissue Engineering
Jie Mi, Jiankun Xu, Hao Yao, Xisheng Li, Wenxue Tong, Ye Li, Bingyang Dai, Xuan He, Dick Ho Kiu Chow, Gang Li, Kathy O. Lui, Jie Zhao, Ling Qin
Summary: The study found that exogenous CGRP promoted bone regeneration and vessel formation in a rat DO model. CGRP increased the fraction of CD31(+)CD144(+) EPCs and capillary density in the bone defect. In vitro, CGRP increased EPC population during endothelial differentiation of BMSCs by activating the PI3K/AKT signaling pathway.
TISSUE ENGINEERING PART A
(2021)
Review
Biochemistry & Molecular Biology
Qichang Wang, Haotian Qin, Jiapeng Deng, Huihui Xu, Su Liu, Jian Weng, Hui Zeng
Summary: Calcitonin gene-related peptide (CGRP) is a 37-amino acid peptide initially known for its vasodilatory and nociceptive effects. Recent research has revealed its close association with bone metabolism and shown CGRP to be a bridge between the nervous system and the skeletal muscle system. CGRP can promote osteogenesis, inhibit bone resorption, stimulate vascular growth, and regulate the immune microenvironment. Various signaling pathways, including the G protein-coupled pathway, MAPK, Hippo, and NF-κB, play a role in CGRP's effects on cell proliferation and differentiation. This review provides a comprehensive overview of the bone repair effects of CGRP and discusses therapeutic approaches such as drug injection, gene editing, and novel bone repair materials.
Article
Medicine, General & Internal
Ilana D. Breen, Caitlin M. Brumfiel, Meera H. Patel, Richard J. Butterfield, Juliana H. VanderPluym, Leroy Griffing, Mark R. Pittelkow, Aaron R. Mangold
Summary: The study found that microvascular complications of CGRP antagonist use in patients with underlying RP are uncommon, but caution is still needed when considering the use of these agents in these patients.
Article
Pharmacology & Pharmacy
Michael L. Garelja, Tyla I. Alexander, Amy Bennie, Mhairi Nimick, Jakeb Petersen, Christopher S. Walker, Debbie L. Hay
Summary: This study demonstrates that erenumab can antagonize both CGRP and AMY(1) receptors, providing insights into the clinical profile of erenumab.
BRITISH JOURNAL OF PHARMACOLOGY
(2023)
Article
Chemistry, Medicinal
Stephen E. Mercer, Prasad V. Chaturvedula, Charles M. Conway, Deborah A. Cook, Carl D. Davis, Sokhom S. Pin, Robert Macci, Richard Schartman, Laura J. Signor, Kimberly A. Widmann, Valerie J. Whiterock, Ping Chen, Cen Xu, John J. Herbst, Walter A. Kostich, George Thalody, John E. Macor, Gene M. Dubowchik
Summary: CGRP receptor antagonist zavegepant has demonstrated efficacy in acute migraine treatment but with low oral bioavailability. By designing a series of compounds, researchers have successfully improved oral bioavailability of a compound while maintaining high affinity binding and in vivo efficacy.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2021)
Article
Neurosciences
Rui-hao Zhang, Xiao-bo Zhang, Yu-bao Lu, Yi-cun Hu, Xiang-yi Chen, De-chen Yu, Jin-tao Shi, Wen-huan Yuan, Jing Wang, Hai-yu Zhou
Summary: This study found that the expression of CGRP in the femur of osteoporotic patients was downregulated, while the expression of CGRP and serotonin in the spinal cord and brainstem was increased. These results suggest that the activation of osteoclasts may trigger the release of CGRP from sensory nerve fibers and promote serotonin release in the spinal cord and brainstem, contributing to bone loss in postmenopausal osteoporosis.
BRAIN RESEARCH BULLETIN
(2021)
Article
Dermatology
Twan Sia, Taylor Webb, Shufeng Li, Leon S. Moskatel, Anne Lynn S. Chang
Summary: This exploratory retrospective study examined the effect of CGRP monoclonal antibodies (mAbs) on rosacea in patients with migraines. The majority of patients experienced improvement in rosacea severity after receiving CGRP mAbs. Prospective, placebo-controlled clinical trials are needed to further evaluate the use of CGRP mAbs in rosacea.
BRITISH JOURNAL OF DERMATOLOGY
(2023)
Editorial Material
Physiology
Kimberly D. Mackenzie, Mario Ortega, Yoel Kessler, Verena Ramirez Campos, Lynda J. Krasenbaum, Karen Carr, Xiaoping Ning, Jennifer Stratton
Summary: Calcitonin gene-related peptide (CGRP) pathway-targeted treatments are effective for preventing and treating migraines, but may cause constipation. However, limited data from a review article do not support the claim that constipation occurs in more than 50% of patients treated with CGRP pathway-targeted treatments.
FRONTIERS IN PHYSIOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Yan Xiong, Han-Xia Wang, Hang Yan, Si-Lu Zhu, Shu-Wen Guo, Wei-Jie Peng, Dan Luo
Summary: The study demonstrates that rutaecarpine upregulates the expression of longevity protein SIRT1 and prevents high glucose-induced endothelial cell senescence through the activation of the TRPV1/[Ca2+]i/CaM signaling pathway.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Yan Xiong, Han-Xia Wang, Hang Yan, Si-Lu Zhu, Shu-Wen Guo, Wei-Jie Peng, Dan Luo
Summary: The study demonstrates that rutaecarpine upregulates SIRT1 expression and prevents high glucose-induced endothelial cell senescence, possibly through activation of the TRPV1/[Ca2+]/CaM signaling pathway.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Lang She, Hua Tu, Yin-Zhuang Zhang, Li-Jing Tang, Nian-Sheng Li, Qi-Lin Ma, Bin Liu, Qingjie Li, Xiu-Ju Luo, Jun Peng
CARDIOVASCULAR DRUGS AND THERAPY
(2019)
Article
Pharmacology & Pharmacy
Tao Li, Xiu-Ju Luo, E-Li Wang, Nian-Sheng Li, Xiao-Jie Zhang, Feng-Lin Song, Jin-Fu Yang, Bin Liu, Jun Peng
EUROPEAN JOURNAL OF PHARMACOLOGY
(2019)
Article
Plant Sciences
Tao Li, Jing-Jie Peng, E-Li Wang, Nian-Sheng Li, Feng-Lin Song, Jin-Fu Yang, Xiu-Ju Luo, Bin Liu, Jun Peng
Article
Pharmacology & Pharmacy
E-Li Wang, Miao-Miao Jia, Fang-Mei Luo, Tao Li, Jing-Jie Peng, Xiu-Ju Luo, Feng-Lin Song, Jin-Fu Yang, Jun Peng, Bin Liu
EUROPEAN JOURNAL OF PHARMACOLOGY
(2019)
Article
Pharmacology & Pharmacy
Kai-Di Ren, Wei-Ning Liu, Jing Tian, Yi-Yue Zhang, Jing-Jie Peng, Di Zhang, Nian-Sheng Li, Jie Yang, Jun Peng, Xiu-Ju Luo
EUROPEAN JOURNAL OF PHARMACOLOGY
(2019)
Review
Biochemistry & Molecular Biology
Li-Qun Lu, Jing Tian, Xiu-Ju Luo, Jun Peng
Summary: Apoptosis, necrosis, and autophagy-dependent cell death are the three major types of cell death. Regulated necrosis, with various forms such as necroptosis, pyroptosis, and ferroptosis, plays a significant role in the progression of injury-relevant diseases. Further research focusing on the crosstalk among different types of regulated necrosis is needed for developing efficient strategies for reducing cardio-cerebrovascular injury.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2021)
Article
Pharmacology & Pharmacy
Li-Jing Tang, Xiu-Ju Luo, Hua Tu, Heng Chen, Xiao-Ming Xiong, Nian-Sheng Li, Jun Peng
Summary: The study evaluated the contribution of ferroptosis to myocardial ischemia or reperfusion injury, finding that ferroptosis mainly occurs during myocardial reperfusion. The use of iron chelator deferoxamine attenuated reperfusion injury but had no significant effect on ischemic injury.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Yi-Yue Zhang, Jing Tian, Zi-Mei Peng, Bin Liu, Ya-Wei Peng, Xiao-Jie Zhang, Zhong-Yang Hu, Xiu-Ju Luo, Jun Peng
Summary: This study demonstrates that caspofungin can suppress brain cell necroptosis in ischemic stroke by upregulating the level of Pellino3.
CARDIOVASCULAR DRUGS AND THERAPY
(2023)
Article
Neurosciences
Yi-Yue Zhang, Xiao-Yan Yang, Hui-Qi Liu, Zheng Zhang, Chang-Ping Hu, Jun Peng, Xiu-Ju Luo
Summary: This study reveals the relationship between HECTD4, GluN2B, and MALT1 in ischemic stroke, showing that the downregulation of HECTD4 leads to calcium overload and brain injury due to the activation of GluN2B and the reduced ubiquitination of GluN2B and MALT1.
MOLECULAR NEUROBIOLOGY
(2023)
Review
Cell Biology
Yi-Yue Zhang, Xi-Sheng Li, Kai-Di Ren, Jun Peng, Xiu-Ju Luo
Summary: Metal homeostasis is crucial for normal brain function and disruptions can lead to neurodegenerative diseases. Metal ions play important roles in CNS development, metabolism, redox reactions, and neurotransmitter transmission. Dysregulation of metal homeostasis can cause neurooxidative stress, excitotoxicity, neuroinflammation, and nerve cell death. This review examines the physiological and pathophysiological functions of metal ions and their channels, as well as their involvement in neurodegenerative diseases. The potential therapeutic targets and current methods of modulating metal ions are discussed.
AGEING RESEARCH REVIEWS
(2023)
Review
Immunology
Yi-Yue Zhang, Kai-Di Ren, Xiu-Ju Luo, Jun Peng
Summary: Neurological symptoms are common in COVID-19 patients and can result in neuronal cell death. This review summarizes the physiological functions of metal ions and their role in COVID-19-induced neurological symptoms. Currently available modulators of metal ions and their channels are discussed. Further research is needed to explore the interactions between different metal ions and their channels, and simultaneous pharmacological intervention of multiple metal signaling pathway disorders may be beneficial in treating COVID-19-induced neurological symptoms.
INFLAMMOPHARMACOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Yi-Yue Zhang, Jing-Jie Peng, Di Chen, Hui-Qi Liu, Bi-Feng Yao, Jun Peng, Xiu-Ju Luo
Summary: Telaprevir, a hepatitis C virus protease inhibitor, can protect against cerebral ischemic injury by inhibiting MALT1 and reducing calcium overload in nerve cells. It also reduces the activation of GluN2B and necroptosis-associated proteins.
ACS CHEMICAL NEUROSCIENCE
(2023)
Article
Pharmacology & Pharmacy
Li-Qun Lu, a Nian-Sheng Li, a Ming-Rui Li, Jiao-Yang Peng, Li-Jing Tang, Xiu-Ju Luo, Jun Peng
Summary: Impaired endothelium-dependent vasodilation in atherosclerosis is a high-risk factor for myocardial infarction and ischemic stroke. DL-3-n-butylphthalide (NBP) improves endothelium-dependent vasodilation by suppressing inflammation, endothelial necroptosis, and apoptosis in atherosclerosis.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2023)
Review
Biochemistry & Molecular Biology
Ming-Rui Li, Xiu-Ju Luo, Jun Peng
Summary: Sonic hedgehog (SHH) signaling plays a crucial role in embryonic development, but its involvement in cardiac, cerebral, and vascular pathophysiology is still debated. Recent studies have shown that SHH signaling affects ion channels, which in turn influence the behavior of target cells in the cardio-cerebrovascular system. This article reviews the cascades of SHH signaling, explores its interaction with ion channels, and highlights the importance of studying its effect on ion homeostasis as a potential mechanism for cardio-cerebrovascular diseases.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
(2023)
Article
Geriatrics & Gerontology
Feng-Juan Li, Cheng-Long Zhang, Xiu-Ju Luo, Jun Peng, Tian-Lun Yang